AIDS Weekly
Susan Hasty, Publisher
Table of Contents . . . March 1st, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
HIV/AIDS Gene Therapy - Novel gp41-derived peptides inhibit HIV cell entry
Pediatric HIV/AIDS - HAART induces abnormal bone metabolism, reduces BMD in children
HIV/AIDS - Microbead-conjugated anti-gp41 antibodies can isolate HIV-infected cells
HIV/AIDS Pathogenesis - C-type lectin DC-SIGN microdomains enable HIV entry
HIV/AIDS Therapy - Lipid membranes likely involved in enfuvirtide activity
HIV/AIDS Therapy - T-20 cross-reactive gp41 antibody does not reduce T-20 efficacy
AIDS Therapy - Three-year data highlight Viread efficacy, safety, and side effect profile
Blood Screening - Procleix Ultrio Assay clinical trials commence
Business & Finance - Company to close Palo Alto facilities, cut workforce, focus on drug discovery
Chronic Fatigue Syndrome - Phase III CFS clinical trial complete
Cognitive Function - Alcohol abuse history could pose problems for HIV patients
Collaborations - Marketing agreement signed for promotion of aspergillus test
Drug Development - Antiretroviral mechanisms of DSB identified
Drug Development - Antiviral and DNA-cleaving activities of fullerene derivatives reviewed
Drug Development - Inhibition of HIV integrase by styrylquinoline derivatives characterized
Facial Lipoatrophy - FDA accepts filing for Sculptra
Finance - Cachexia drug developer secures $12M in financing
Fungal Infection - Whole genome optical map completed of world's most frequent fungal infection
HIV Prevention - LA County to intensify fight against HIV, STDs in gay bathhouses
HIV Transmission - Rate in U.S. is approximately 4% per year
HIV/AIDS - AIDS threatens Mozambique teachers and students
HIV/AIDS - Bayesian inference used to clarify evolutionary relationship of HIV, SIV
HIV/AIDS - Bulgarians in AIDS trial supported by Libyan virologist
HIV/AIDS - HIV discrimination case settled by surgeon
HIV/AIDS Dementia - CXCR4 mediates gp120 neurotoxicity in cerebellar granule cells
HIV/AIDS Epidemiology - AIDS rising in black male college students
HIV/AIDS Epidemiology - HIV rates, risk factors among different IDU types determined
HIV/AIDS Funding - Geneva-based agency to provide India with funds to prevent AIDS
HIV/AIDS Infection - HIV among pregnant women at Mexican hospital much higher than reported earlier
HIV/AIDS Opportunistic Infection - Enyzme immunoassay suitable for cryptosporidiosis diagnosis
HIV/AIDS Opportunistic Infection - Murine T cytotoxic-1 CD8 cells are effector cells against P. carinii
HIV/AIDS Proteomics - Pol incorporation into Gag VLPs is independent of upstream Gag domain
HIV/AIDS Proteomics - Protease activity regulates Env-mediated membrane fusion
HIV/AIDS Public Health - Social networks and oral testing improve minority HIV screening rates
HIV/AIDS RNA Research - Nucleocapsid-RNA interactions crucial for stability, but not assembly
HIV/AIDS Receptor Studies - Internalization and recycling mechanisms of CCR5 clarified
HIV/AIDS Therapy - Effects of indinavir on sterol, fatty acid homeostasis clarified
HIV/AIDS Therapy - Houston firm set to begin human trials of new HIV treatment
HIV/AIDS Therapy - Injection drug use attenuates HAART benefits
HIV/AIDS Therapy - Methamphetamines augment HIV replication in humans
HIV/AIDS Treatment - December price hike on AIDS medicine under investigation
HIV/AIDS Treatment - LA-based AIDS care group sues over huge increase in cost of drug
HIV/AIDS Treatment - Two-drug regimen can reduce vertical transmission risk to below 2%
HIV/AIDS Vaccine - Measles virus expressing HIV proteins induces antibodies to HIV
HIV/AIDS Vaccine - Monoclonal antibodies show promise for AIDS vaccines
HIV/HBV Coinfection - HBV treatment can lead to recovery of virus-specific T-cell responses
Healthcare Access - HIV treatment as a human right - learning from Thailand's experience
Healthcare Access - Nigerian AIDS sufferers complain that shortages and corruption threaten lives
Hepatitis C Virus - Highest therapy response rates to date seen in coinfected patients
Hepatitis Virus - Clinical trials of Procleix Ultrio Assay begin on Procleix Tigris system
Immunology - HIV exhausts the immune system through chronic nonspecific activation
Legal Issues - Prosecutors investigating December price hike on AIDS medicine
Patents - Patent granted for EradicAide technology to diagnose, prevent, treat AIDS
Pediatric HIV/AIDS - Production of drug-sensitive HIV continues in children during successful HAART
Perinatal HIV - Nevirapine plus zidovudine to prevent perinatal HIV in Thailand
Perinatal HIV - Stopping AIDS spread to newborns may harm mothers
Personnel - Biopharmaceutical company appoints Kevin Reilly to board of directors
Personnel - Biotechnology company appoints new member to board of directors
Pharmacokinetics - Pharmacokinetics of emtricitabine in HIV-infected children determined
Public Health - Should compulsory screening of immigrants be part of U.K. policy?
Restructuring - Biopharmaceutical research company reduces debt
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
